American Society of Hematology, Blood Advances, 9(4), p. 1859-1866, 2020
DOI: 10.1182/bloodadvances.2019001325
Full text: Download
Key Points Diagnostic and relapse diffuse large B-cell lymphoma (DLBCL) biopsies reveal increased mutational burden/loss of heterozygosity in HLA-A. Serially sampled tumor biopsies provide insight into therapeutic targets and evolutionary divergence in relapsed/refractory DLBCL.